Literature DB >> 12428922

Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint.

M Stuschke1, A Sak, R Wurm, B Sinn, G Wolf, G Stüben, V Budach.   

Abstract

PURPOSE: To characterize the relationship between cell-cycle progression and radiation-induced apoptosis in NSCLC cell lines with different p53 status.
MATERIALS AND METHODS: Cell lines with functional (H460, A549) and non-functional p53 (H661 and H520) were irradiated with 20 Gy. Multiparameter flow-cytometry was used to follow the progression of synchronized cells through the cell cycle after irradiation.
RESULTS: Delayed apoptosis was observed after cell-cycle progression beyond the G2 block, either in the late G2/M-phase of the same cell cycle being irradiated (H661, H520) or in the G1-phase of the subsequent cell cycle (H460, A549). The apoptotic fraction in H661 and H520 was 60-80% at 144h after irradiation, higher than in A549 and H460 (5 and 35%, respectively). As an alternative to apoptosis in cells cycling beyond the G2 restriction point, hyperploid cells were generated by all cell lines. Inhibition of cell-cycle progression through the G2/M-phase efficiently reduced the induction of late apoptosis. After irradiation in S-phase, 50-60% of cells with functional p53 remained arrested at the G2 restriction point until 144 h post-irradiation, while only 20% of the H661 or H520 did so.
CONCLUSIONS: These data characterize radiation-induced apoptosis in NSCLC cell lines as a removal pathway of clonogenically inactivated cells secondary to cell-cycle progression beyond G2/M, and is unlikely to be a critical factor for cellular radiation sensitivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428922     DOI: 10.1080/09553000210148903

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  8 in total

1.  USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.

Authors:  Deepa Kushwaha; Colin O'Leary; Kyle R Cron; Peter Deraska; Kaya Zhu; Alan D D'Andrea; David Kozono
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Effect of separase depletion on ionizing radiation-induced cell cycle checkpoints and survival in human lung cancer cell lines.

Authors:  A Sak; I Fegers; M Groneberg; M Stuschke
Journal:  Cell Prolif       Date:  2008-06-19       Impact factor: 6.831

3.  Effects of X-radiation on lung cancer cells: the interplay between oxidative stress and P53 levels.

Authors:  Fernando Mendes; Tiago Sales; Cátia Domingues; Susann Schugk; Ana Margarida Abrantes; Ana Cristina Gonçalves; Ricardo Teixo; Rita Silva; João Casalta-Lopes; Clara Rocha; Mafalda Laranjo; Paulo César Simões; Ana Bela Sarmento Ribeiro; Maria Filomena Botelho; Manuel Santos Rosa
Journal:  Med Oncol       Date:  2015-11-18       Impact factor: 3.064

4.  Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines.

Authors:  A Sak; G Stueben; M Groneberg; W Böcker; M Stuschke
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

5.  Radiation-induced autophagy contributes to cell death and induces apoptosis partly in malignant glioma cells.

Authors:  Guk Heui Jo; Oliver Bögler; Yong-Joon Chwae; Heon Yoo; Seung Hoon Lee; Jong Bae Park; Youn-Jae Kim; Jong Heon Kim; Ho-Shin Gwak
Journal:  Cancer Res Treat       Date:  2014-08-29       Impact factor: 4.679

6.  mRNA and microRNA expression profiles of radioresistant NCI-H520 non-small cell lung cancer cells.

Authors:  Wei Guo; Li Xie; Long Zhao; Yuehuan Zhao
Journal:  Mol Med Rep       Date:  2015-04-08       Impact factor: 2.952

7.  Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer.

Authors:  Kyle R Cron; Kaya Zhu; Deepa S Kushwaha; Grace Hsieh; Dmitry Merzon; Jonathan Rameseder; Clark C Chen; Alan D D'Andrea; David Kozono
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

8.  Additive interaction of gefitinib ('Iressa', ZD1839) and ionising radiation in human tumour cells in vitro.

Authors:  N Giocanti; C Hennequin; D Rouillard; R Defrance; V Favaudon
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.